Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1991-02-22
1994-01-18
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514533, 514538, 514539, 514617, 514650, 514654, A61K 3113, A61K 31135, A61K 31235, A61K 3124
Patent
active
052800466
ABSTRACT:
Provided is a method for treating Type I diabetes in mammals utilizing certain phenol and benzamide compounds.
REFERENCES:
patent: 3043774 (1962-07-01), Coffield
patent: 3305483 (1967-02-01), Coffield
patent: 3489684 (1970-01-01), O'Shea
patent: 3809761 (1974-05-01), Lerner
patent: 3994828 (1976-11-01), Zaffaroni
patent: 4116930 (1978-09-01), Dexter et al.
patent: 4128664 (1978-12-01), Moore
patent: 4237165 (1980-12-01), Duhault
patent: 4532356 (1985-07-01), Everly et al.
patent: 4829061 (1989-05-01), Wolf et al.
patent: 4948813 (1990-08-01), Wilkerson
patent: 4959503 (1990-09-01), Connor et al.
patent: 5011928 (1991-04-01), Venero et al.
patent: 5087743 (1992-02-01), Janssen et al.
Horii et al., J. Med. Chem., 29(6), 1038-1046 (1986).
Patent Abst. of Japan, vol. 12, No. 467 (C-550) [3314](1988).
Chemical Abstracts, 103, 104629y (1985).
Diabetes Mellitus, 8th Ed., Eli Lilly and Company, Indianapolis, Ind. pp. 12-17 (1979).
Chemical Abstracts, 74, 96312e (1971).
Derwent Abstracts, 339971-B (abstracting JA-7217306-R) (1990).
Derwent Abstracts, 20,547 (1990).
Chemical Abstracts, 73, 86385w (1970).
Chemical Abstracts, 66, 16925d (1967).
Chemical Abstracts, 109, 1290447u (1988).
Chemical Abstracts, 78, 132326f (1973).
Chemical Abstracts, 74, 40916n (1971).
Chemical Abstracts, 97, 200429m (1982).
Chemical Abstracts, 88, 38847m (1978).
Chemical Abstracts, 88, 192135j (1978).
Chemical Abstracts, 95, 82029q (1981).
Chemical Abstracts, 76, 73628q (1972).
Chemical Abstracts, 77, 141203v (1972).
Chemical Abstracts, 91, 212411p (1979).
Chemical Abstracts, 100, 35563w (1984).
Chemical Abstracts, 107, 42468s (1987).
Derwent Abstracts 84-076585/13 (1990).
Derwent Abstracts 88-193658/28 (1990).
Chemical Abstracts, 109, 110014j (1988).
Derwent Abstracts 87-076373/11 (1990).
Lafferty et al., J. of Autoimmun., 3 (Suppl.), 75 (1990).
Wang et al., Transplantation 46 (Suppl.), 1015 (1988).
Okamoto, Biomed. Biochim. Acta, 44(1), 15 (1985).
"The Pathogenesis of Immunologically Mediated Diabetes", Autoimmunity and the Pathogenesis of Diabetes, Ginsberg-Fellner et al., ed., Springer-Verlag, New York, pp. 185-205 (1989).
Nomikos et al., Immunol. Cell Biol., 67, 85 (1989).
Wang et al., Abstract from the Keystone Symposium on the Molecular Basis of Oxidative Damage by Leukocytes (Jan. 28-Feb. 1, 1991).
Lafferty Kevin
Panetta Jill A.
Demeter John C.
Goldberg Jerome D.
Taylor Douglas J.
The University of Colorado Foundation Inc.
Whitaker Leroy
LandOfFree
Method of treating type I diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating type I diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating type I diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1136666